Skip to search formSkip to main contentSkip to account menu

2-Bromoergocryptine Mesylate

Known as: Bromocriptine Mesylate, 2-Bromoergocryptine Mesylate [Chemical/Ingredient], Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)- 
The mesylate salt of bromocriptine, a semisynthetic ergot alkaloid with dopaminergic, antidyskinetic, and antiprolactinemic activities. Bromocriptine… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
BACKGROUND Patients with Parkinson disease (PD) treated with the nonergot dopamine agonists pramipexole dihydrochloride and… 
Review
1998
Review
1998
Secreting and nonsecreting pituitary adenomas account for 10% of all intracranial tumors. Because most of these adenomas are… 
Review
1996
Review
1996
Acute myocardial infarction rarely occurs in women of childbearing age and has been estimated to occur in only 1 in 10 000 women… 
Review
1994
Review
1994
Pituitary adenomas in women of childbearing age present a potential contraindication to pregnancy because of the risk for… 
Highly Cited
1993
Highly Cited
1993
Restless legs syndrome (RLS) is a common neurosensorimotor disorder that presents with paresthesias, sleep disturbances and, in… 
Highly Cited
1987
Highly Cited
1987
Amantadine hydrochloride and bromocriptine mesylate were compared on a double-blind basis for withdrawal from cocaine dependence… 
Highly Cited
1983
Highly Cited
1983
THE NEUROLEPTIC malignant syndrome (NMS) is characterized by severe extrapyramidal dysfunction, hyperthermia, and autonomic… 
Highly Cited
1983
Highly Cited
1983
Neuroleptic malignant syndrome, a rare but potentially fatal side effect of antipsychotic medications, has often proven… 
Highly Cited
1982
Highly Cited
1982
Information was collected on the outcome of 1,410 pregnancies in 1,335 women to whom bromocriptine mesylate (Parlodel) had been…